Eyeworld

EW REFRACTIVE 64 January 2019 Refractive roundtable ing our fellow and residents to do FLACS. Dr. Thompson: I was an early adopter of femto and was involved in the research. I have used it since 2010 but then as of late it has been decreasing. Dr. Vukich: I was involved in some of the early clinical research and some of the early development of the femtosecond laser platform. We do not currently use that technology in our practice, and I'm interested to explore where the value is and how this might benefit or if this is a segment that we can expect to grow or perhaps level off. I think we have a lot of interest and there is certainly a lot of experience in the room here. Dr. Thompson: To start out, we all want to do our best in patient education, we all have our different styles. One philosophy is to educate more on vision benefits. The other is to dive into some of the details had it for about 18 months now. We do about 60% of our cases with it and like it, have been happy with the experience. Dr. Waring: We were relatively early adopters of femtosecond technology for lens surgery, beginning in 2012. I've had a wonderful experience, it has rapidly grown adoption in our practice, and currently we're at about 90% use for the femtosecond laser in cataract surgery. Dr. Dell: I started performing femto- second cataract surgery in 2010, and I've used two platforms. Dr. Clinch: We were early adopters in 2011. We've used two different platforms. I think there has been a paradigm shift among the plat- forms, and I've done approximately 3,000–4,000 cases. Dr. Nehls: We've had the femtosec- ond laser for 2 years. Twenty-five percent of my cases are done with femtosecond laser-assisted cataract surgery (FLACS). I am also train- an edited transcript of the first part of the discussion. Dr. Vukich: Thank you very much for attending the joint EyeWorld/ ASCRS Refractive Surgery Clinical Committee roundtable. This evening we're going to discuss whether femtosecond laser-assisted cataract surgery adds value to a premium practice. Dr. Thompson: Let's start with everyone briefly introducing their experiences with femtosecond la- ser-assisted cataract surgery. Dr. Zaldivar: We were one of the early adopters of this technology. At the beginning we were disappointed because the results weren't as we expected. Interestingly, this year we have returned, and we are happy with the results. We have found the place in our practice, how to fit it in, and are starting to use it on a regular basis. Dr. Williamson: I'm probably the newest to this technology. We've A roundtable from the 2018 ASCRS•ASOA Annual Meeting with leaders in refractive surgery On April 15, 2018, during the 2018 ASCRS•ASOA Annual Meeting, John Vukich, MD, surgical director, Davis Duehr Dean Centre for Refractive Sur- gery, Madison, Wisconsin, and Vance Thompson, MD, Vance Thompson, Vision Sioux Falls, South Dakota, moderated a discussion on whether femtosecond laser-assisted cataract surgery adds value to a premium practice. The participants were Roger Zaldivar, MD, MSc, MBA, Insti- tuto Zaldivar, Mendoza, Argentina, Blake Williamson, MD, Williamson Eye Center, Baton Rouge, Louisiana, George Waring, MD, Waring Vision Institute, Mt. Pleasant, South Carolina, Steven Dell, MD, Dell Laser Consul- tants, Austin, Texas, Thomas Clinch, MD, Eye Doctors of Washington, Chevy Chase, Maryland, and Sarah Nehls, MD, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin. The following is Does femtosecond laser-assisted cataract surgery add value to a premium practice? Dr. Nehls and Dr. Thompson at the roundtable continued on page 66 Dr. Zaldivar and Dr. Williamson

• Blank Page
• Blank Page (1)